Liyun Xu

机构：Zhejiang International Studies University, Central South University, Wenzhou Medical University, Zhoushan Hospital, Affiliated Zhongshan Hospital of Dalian University, Second Xiangya Hospital of Central South University · ORCID：0000-0002-0125-5588

发表论文 58 篇 · 总被引 2044 次 · h-index 23

代表论文

• IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers (2022 · Frontiers in Immunology · 被引 144)
• IL‐6 promotes metastasis of non‐small‐cell lung cancer by up‐regulating TIM‐4 via NF‐κB (2020 · Cell Proliferation · 被引 143)
• SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker (2018 · BMB Reports · 被引 74)
• Hepatic Macrophage as a Key Player in Fatty Liver Disease (2021 · Frontiers in Immunology · 被引 67)
• Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance (2024 · Cell Reports Medicine · 被引 58)
• TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axis (2023 · Cell Death and Disease · 被引 46)